First In Human By Vial
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO with episodes launching weekly on Tuesday's.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: https://vial.com
Follow us on social media for real-time insights:
Twitter: https://twitter.com/VialTrials
LinkedIn: https://www.linkedin.com/company/vialtrials
Episodes
62 episodes since 2022
Episode 62: Josh Mandel-Brehm - CEO, CAMP4 Therapeutics
Explore the untapped potential of RNA amplifying therapeutics with the CEO of CAMP4 Therapeutics, Josh Mandel-Brehm. We uncover the power of antisense oligonucleotides in rewriting the narrative for genetic diseases characterized by prote...
May 14, 2024
•
Season 2
•
Episode 62
•
20:10
Episode 61: William Korinek - CEO and Co-Founder, Astrocyte Pharmaceuticals
Embark on a journey through the neurons and synapses of brain science with William Korinek, the CEO of Astrocyte Pharmaceuticals. In a conversation that fuses the molecular intricacies of neuroprotection with the humanistic pursuit of medical a...
May 07, 2024
•
Season 2
•
Episode 61
•
24:20
Episode 60: Rachel Haines - VP of Clinical Development & Operations, Rinri Therapeutics
In this episode, Rachel Haines from Rinri Therapeutics joins us to discuss the possibilities of cell therapy for hearing loss. Our conversation with Rachel goes beyond just scientific innovation; we also explore the potential impact of Rinr...
April 23, 2024
•
18:30
Episode 59: Bas van der Baan - President & CEO, Lixte Biotechnology
Join as we dive deep into the world of oncology drug development with Bas van der Baan of Lixte. Discover the inspiration behind Lixte's focus on PP2A inhibitors and how this innovative approach is poised to revolutionize cancer treatment by en...
April 16, 2024
•
Season 2
•
Episode 59
•
17:32
Episode 58: Samarendra Mohanty - President & CSO, Nanoscope Therapeutics
Dr. Samar Mohanty, president and CSO of Nanoscope Therapeutics joins us to shed light on the revolutionary gene therapy that's giving hope to individuals with retinal degenerative diseases by pioneering a treatment that can re-sensitize the ret...
March 26, 2024
•
Season 2
•
Episode 58
•
16:36
Episode 57: Rob Etherington- CEO and President at Clene Nanomedicine
Imagine unlocking the secrets to revitalizing the brain's energy centers and turning the tide on neurodegenerative diseases. In this episode, Rob introduces us to CNM-Au8, an oral nanotherapeutic with the potential to recharge failing mitochond...
March 12, 2024
•
Season 2
•
Episode 57
•
20:06
Episode 56: Jason Bock- Founder and CEO at CTMC
Step into the future as Dr. Jason Bock, founder and CEO of CTMC discusses the company's unique approach to accelerating cell therapies from development to testing, and the power of collaboration in reshaping the future of cancer treatment. List...
March 05, 2024
•
Season 2
•
Episode 56
•
22:28
Episode 55: Alex Federation- Co-Founder at Talus Bio
Embark on a quest to unravel the 'undruggable' genome with Alex Federation, Co-founder of Talus Bio. Explore challenges in targeting transcription factors in cancer with Talus's innovative Marmot platform. Discover potential breakthroughs in ra...
February 27, 2024
•
Season 2
•
Episode 55
•
15:27
Episode 54: Ahmed Hamdy- CEO at Vincerx Pharma
Join Dr. Ahmed Hamdy, CEO of Vincerx Pharma, on a compelling journey through oncology. From co-founding Acerta Pharma to pioneering patient-centric innovations, Dr. Hamdy shares his impactful career. Explore the groundbreaking VersAptxbioco...
February 20, 2024
•
Season 2
•
Episode 54
•
16:52
Episode 53: Sam Clark- CEO & Founder at Terran Biosciences
Have you ever considered the untapped potential of abandoned drugs? Join Dr. Sam Clark to discuss how his personal drive to combat mental illness is leading to breakthroughs in treatments for neurological and psychiatric diseases. Witness how T...
February 13, 2024
•
Season 2
•
Episode 53
•
18:10
Episode 52: Mark McDonough- President & CEO of ChromaCode
Ever wondered how technology could drastically improve early detection in healthcare? Let us take you on a journey with Mark McDonough, President and CEO of ChromaCode, as we unfold the world of molecular diagnostics with a special focus on HDP...
February 06, 2024
•
Season 2
•
Episode 52
•
16:54
Episode 51: Bogdan Knezevic - Co-founder & CEO at Kaleidoscope.bio
Embark on a journey through the intricate world of biotech with Bogdan Kezevic, co-founder and CEO of Kaleidoscope Bio, and uncover the revolutionary software shaping the future of scientific research. Bogdan's leap from scientist to entreprene...
January 30, 2024
•
Season 2
•
Episode 51
•
21:16
Episode 50: Steven Reed - Co-Founder & CEO at HDT Bio
What does it take to revolutionize the world of vaccines and touch lives across the globe? Join us on a riveting journey with Steven Reed, CEO and co-founder of HDT-Bio, as we explore the creation of the first refined tuberculosis vaccine and d...
January 23, 2024
•
Season 2
•
Episode 50
•
12:19
Episode 49: Jeffrey Bacha - Chairman, Rakovina Therapeutics
Join Jeffrey Bacha, a pioneer in the fight against cancer and the creative force behind Rakovina Therapeutics. For 25 years, Jeffrey has been reshaping the industry landscape, and today, he gives us a peek into his world of innovation. We ventu...
December 19, 2023
•
Season 2
•
Episode 49
•
21:45
Episode 48: Jonathan Thon - Founder & CEO at STRM.BIO
Embark on a fascinating exploration of biotech entrepreneurship, guided by an expert who's been in the trenches: Jonathan Thon, CEO and founder of STRM.BIO. We'll give you an insider's view of his journey from academia to the cutting edge of bi...
December 12, 2023
•
Season 2
•
Episode 48
•
21:52
Episode 47: Oscar Segurado- CMO at ASC Therapeutics
Ever wondered how far we've truly come in the realm of gene and cell therapies, and where we're headed next? This captivating conversation with Oscar Segurado, the CMO of ASC Therapeutics, will satisfy your curiosity. Oscar, a veteran in the bi...
December 05, 2023
•
Season 2
•
Episode 47
•
22:00
Episodes 46: Spiro Rombotis- CEO at Cyclacel
We’re thrilled to share our enlightening exchange with Spiro Rombotis, the seasoned CEO of Cyclacel. He peels back the curtain on the breakthrough discovery of B53, a commonly mutated gene in cancer patients, and the inspiring success of FADRA,...
November 28, 2023
•
Season 2
•
Episode 46
•
21:28
Episode 45: Frank Borriello- Founder and CEO at Alloplex Biotherapeutics
Ever wondered about the people who are leading the fight against cancer, developing groundbreaking treatments, and changing lives? Meet Frank Boriello, the mind behind SUPLEXA cell therapy, and the CEO and founder of Alloplex Biotherapeutics. I...
October 24, 2023
•
Season 2
•
Episode 45
•
17:56
Episode 44: Max Darnell- CEO & Co-Founder at Modulus Therapeutics
Max Darnell, CEO and co-founder of Modulus Therapeutics, takes us through his thrilling journey from bioengineering and systems biology to launching a biotech startup. Max unveils how his team's curiosity and motivation, along with their high t...
October 17, 2023
•
Season 2
•
Episode 44
•
14:18
Episode 43: Pepper Landson- Co-Founder & CEO of Praetego
Join 30-year industry veteran Pepper Landson, Co-founder and CEO of Praetego as she shares her inspiring journey that led her to tackle Alzheimer's and dementia through the innovative use of amadorins. Pepper's intriguing narrative not on...
October 10, 2023
•
Season 2
•
Episode 43
•
19:03
Episode 42: Dr. Timothy Miller - Co-Founder, President, & CEO at Forge Biologics
Ever wonder how the complexities of gene therapies are addressed from bench to bedside? The creative solutions lie within the innovative approaches of seasoned professionals like Dr. Timothy Miller, Co-Founder, President, & CEO at Forge Bio...
September 26, 2023
•
Season 2
•
Episode 42
•
12:34
Episode 41: David Esposito - President and CEO at ONL Therapeutics
What if your vision could be saved by the precise application of innovative biotech? Join us as we talk to David Esposito, President & CEO of ONL Therapeutics, and delve deep into his take on leadership. He shares how his military bac...
September 19, 2023
•
Season 2
•
Episode 41
•
19:35
Episode 40: Alfredo Andere - Co-Founder & CEO at LatchBio
Does the convergence of tech and biology hold the key to reshaping biotech's data infrastructure? Our recent chat with Alfredo Andere, Co-Founder and CEO at LatchBio, certainly supports this notion. This episode offers a deep dive into Alfredo'...
September 12, 2023
•
Season 2
•
Episode 40
•
24:41
Episode 39: Lucas Siow - CEO & Co-Founder at ProteinQure
Embark on a journey into the forefront of biotech with Lucas Siow, the visionary behind ProteinQure, as he unveils the impact ...
September 05, 2023
•
Season 2
•
Episode 39
•
15:05
Episode 38: Stephen Doyle - Chief Business Officer at ASLAN Pharmaceuticals
For episode 38, we sit down with Stephen Doyle, Chief Business Officer at ASLAN Pharmaceuticals. Find out more about the challenges involved in developing innovative treatments and how ASLAN is addressing those difficulties as they work to brin...
June 20, 2023
•
Season 1
•
Episode 38
•
21:38